The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)
NCT00145691
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Agitation Aggression in Dementia
Interventions
DRUG:
Oxcarbazepine
Sponsor
Sykehuset Innlandet HF